290 related articles for article (PubMed ID: 38637851)
21. [Gut Microbiome and Colorectal Cancer].
Gweon TG
Korean J Gastroenterol; 2023 Aug; 82(2):56-62. PubMed ID: 37621240
[TBL] [Abstract][Full Text] [Related]
22. Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application.
Zhuang YP; Zhou HL; Chen HB; Zheng MY; Liang YW; Gu YT; Li WT; Qiu WL; Zhou HG
Biomed Pharmacother; 2023 Sep; 165():115040. PubMed ID: 37364479
[TBL] [Abstract][Full Text] [Related]
23. Gut microbiota alterations are distinct for primary colorectal cancer and hepatocellular carcinoma.
Jia W; Rajani C; Xu H; Zheng X
Protein Cell; 2021 May; 12(5):374-393. PubMed ID: 32797354
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies.
Kang Y; Pan W; Cai Y
Z Gastroenterol; 2017 Sep; 55(9):872-880. PubMed ID: 29186641
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and safety of herbal formulas with the function of gut microbiota regulation for gastric and colorectal cancer: A systematic review and meta-analysis.
Xu B; Wang X; Wang H; Cao L; Ge Y; Yuan B; Gao R; Li J
Front Cell Infect Microbiol; 2022; 12():875225. PubMed ID: 35992176
[TBL] [Abstract][Full Text] [Related]
26. Berberine inhibits high fat diet-associated colorectal cancer through modulation of the gut microbiota-mediated lysophosphatidylcholine.
Chen H; Ye C; Wu C; Zhang J; Xu L; Wang X; Xu C; Zhang J; Guo Y; Yao Q
Int J Biol Sci; 2023; 19(7):2097-2113. PubMed ID: 37151876
[TBL] [Abstract][Full Text] [Related]
27. Intervention on gut microbiota may change the strategy for management of colorectal cancer.
Taghinezhad-S S; Mohseni AH; Fu X
J Gastroenterol Hepatol; 2021 Jun; 36(6):1508-1517. PubMed ID: 33295040
[TBL] [Abstract][Full Text] [Related]
28. Role of Gut Microbiota in the Development and Treatment of Colorectal Cancer.
Lin C; Cai X; Zhang J; Wang W; Sheng Q; Hua H; Zhou X
Digestion; 2019; 100(1):72-78. PubMed ID: 30332668
[TBL] [Abstract][Full Text] [Related]
29. Dietary modulation of gut microbiota in patients with colorectal cancer undergoing surgery: A review.
Martínez-Montoro JI; Martínez-Sánchez MA; Balaguer-Román A; Gil-Martínez J; Mesa-López MJ; Egea-Valenzuela J; Ruiz-Alcaraz AJ; Queipo-Ortuño MI; Ferrer M; Fernández-García JC; Ramos-Molina B
Int J Surg; 2022 Aug; 104():106751. PubMed ID: 35803517
[TBL] [Abstract][Full Text] [Related]
30. Gut microbiota correlates with antitumor activity in patients with mCRC and NSCLC treated with cetuximab plus avelumab.
Martini G; Ciardiello D; Dallio M; Famiglietti V; Esposito L; Corte CMD; Napolitano S; Fasano M; Gravina AG; Romano M; Loguercio C; Federico A; Maiello E; Tuccillo C; Morgillo F; Troiani T; Di Maio M; Martinelli E; Ciardiello F
Int J Cancer; 2022 Aug; 151(3):473-480. PubMed ID: 35429341
[TBL] [Abstract][Full Text] [Related]
31. Gut microbiota modulation: a tool for the management of colorectal cancer.
Wang Y; Li H
J Transl Med; 2022 Apr; 20(1):178. PubMed ID: 35449107
[TBL] [Abstract][Full Text] [Related]
32. Gut microbiome and colorectal adenomas.
Dulal S; Keku TO
Cancer J; 2014; 20(3):225-31. PubMed ID: 24855012
[TBL] [Abstract][Full Text] [Related]
33. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.
Nenkov M; Ma Y; Gaßler N; Chen Y
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200820
[TBL] [Abstract][Full Text] [Related]
34. Microbe-based management for colorectal cancer.
Gao ZY; Cui Z; Yan YQ; Ning LJ; Wang ZH; Hong J
Chin Med J (Engl); 2021 Dec; 134(24):2922-2930. PubMed ID: 34855639
[TBL] [Abstract][Full Text] [Related]
35. The role of gut microbiota in the development of colorectal cancer: a review.
Koyande N; Gangopadhyay M; Thatikonda S; Rengan AK
Int J Colorectal Dis; 2022 Jul; 37(7):1509-1523. PubMed ID: 35704091
[TBL] [Abstract][Full Text] [Related]
36. Gut microbiota: A novel and potential target for radioimmunotherapy in colorectal cancer.
Yuan H; Gui R; Wang Z; Fang F; Zhao H
Front Immunol; 2023; 14():1128774. PubMed ID: 36798129
[TBL] [Abstract][Full Text] [Related]
37. Vitamin D and colorectal cancer: Chemopreventive perspectives through the gut microbiota and the immune system.
Rinninella E; Mele MC; Raoul P; Cintoni M; Gasbarrini A
Biofactors; 2022 Mar; 48(2):285-293. PubMed ID: 34559412
[TBL] [Abstract][Full Text] [Related]
38. Role of the Gut Microbiota and Its Metabolites in Tumorigenesis or Development of Colorectal Cancer.
Qu R; Zhang Y; Ma Y; Zhou X; Sun L; Jiang C; Zhang Z; Fu W
Adv Sci (Weinh); 2023 Aug; 10(23):e2205563. PubMed ID: 37263983
[TBL] [Abstract][Full Text] [Related]
39. Gut Microbiota Manipulation as a Tool for Colorectal Cancer Management: Recent Advances in Its Use for Therapeutic Purposes.
Perillo F; Amoroso C; Strati F; Giuffrè MR; Díaz-Basabe A; Lattanzi G; Facciotti F
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751239
[TBL] [Abstract][Full Text] [Related]
40. Effects of prebiotic supplement on gut microbiota, drug bioavailability, and adverse effects in patients with colorectal cancer at different primary tumor locations receiving chemotherapy: study protocol for a randomized clinical trial.
Chen Y; Liao X; Li Y; Cao H; Zhang F; Fei B; Bao C; Cao H; Mao Y; Chen X; Gao X; Zhao W; Xu J
Trials; 2023 Apr; 24(1):268. PubMed ID: 37046334
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
